487 filings
Page 7 of 25
6-K
fmtf69g zvi
7 Jun 22
Report of Foreign Private Issuer
5:00pm
6-K
8k01yafz6ry ot1ka
19 May 22
Report of Foreign Private Issuer
8:00am
6-K
itbsdqmj 8nt85ee61i8
17 May 22
Report of Foreign Private Issuer
8:32am
424B3
7tw 8ifakrymkc5
17 May 22
Prospectus supplement
8:30am
SC 13D/A
uhfj3q5jl q31hz6d
13 May 22
Altamira Therapeutics / Meyer Thomas ownership change
8:32am
EFFECT
6tgfhtb70t d3
26 Apr 22
Notice of effectiveness
12:15am
424B3
er3p1 oe6
25 Apr 22
Prospectus supplement
5:09pm
CORRESP
d6zehzs
22 Apr 22
Correspondence with SEC
12:00am
EFFECT
szig06m7t qk
20 Apr 22
Notice of effectiveness
12:15am
UPLOAD
92npsj
20 Apr 22
Letter from SEC
12:00am
6-K
80tmmcw555l3wijns d9
18 Apr 22
Notice of the Annual General Meeting of Shareholders
7:30am
F-3
hi4 zast50d6c1
14 Apr 22
Shelf registration (foreign)
4:53pm
POS AM
6bzknl4r0wai0s4
14 Apr 22
Prospectus update (post-effective amendment)
4:52pm
6-K
l0x99
4 Mar 22
Altamira Therapeutics and Nuance Pharma Enter into Exclusive Licensing and Distribution Agreement for Bentrioâ„¢ in China and Additional Asian Markets
4:01pm
EFFECT
yp5vf qdq0x9kg
18 Feb 22
Notice of effectiveness
12:15am
424B3
ibgp2qcy78p3disa
17 Feb 22
Prospectus supplement
4:07pm
CORRESP
yum n50giboq4sfx33rc
15 Feb 22
Correspondence with SEC
12:00am
UPLOAD
ueavkdgk7w5x54
14 Feb 22
Letter from SEC
12:00am
F-1
p2b7 btx42m
8 Feb 22
Registration statement (foreign)
5:11pm